Advertisement
UK markets closed

  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     

  • FTSE 250

    20,164.54
    +112.24 (+0.56%)
     

  • AIM

    771.53
    +3.42 (+0.45%)
     

  • GBP/EUR

    1.1673
    +0.0021 (+0.18%)
     

  • GBP/USD

    1.2578
    +0.0031 (+0.25%)
     

  • Bitcoin GBP

    51,015.53
    +238.27 (+0.47%)
     

  • CMC Crypto 200

    1,383.90
    +71.27 (+5.43%)
     

  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     

  • DOW

    38,675.68
    +449.98 (+1.18%)
     

  • CRUDE OIL

    78.88
    +0.77 (+0.99%)
     

  • GOLD FUTURES

    2,324.90
    +16.30 (+0.71%)
     

  • NIKKEI 225

    38,236.07
    -38.03 (-0.10%)
     

  • HANG SENG

    18,578.30
    +102.38 (+0.55%)
     

  • DAX

    18,176.02
    +174.42 (+0.97%)
     

  • CAC 40

    8,024.24
    +66.67 (+0.84%)
     

Clover Health to Report First Quarter 2024 Financial Results on May 7, 2024

Clover Health Investments, Corp.
·1-min read
Clover Health Investments, Corp.
Clover Health Investments, Corp.

FRANKLIN, Tenn., April 23, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will report first quarter 2024 financial results after market close on Tuesday, May 7, 2024. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on May 7, 2024, to discuss the Company’s business and financial results.

First Quarter 2024 Conference Call and Webcast Details:

  • What: Clover Health First Quarter 2024 Earnings Conference Call

  • When: Tuesday, May 7, 2024, at 5:00 p.m. Eastern Time

  • Dial In: To access the call via telephone please dial 800-579-2543 (for U.S. callers) or 785-424-1789 (for callers outside the U.S.) and enter the conference ID: CLOVQ124

  • Webcast: A live and archived webcast of the conference call will be accessible from the Investor Relations section of the Company’s website at https://investors.cloverhealth.com/ for 12 months

ADVERTISEMENT

About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement company committed to bringing access to great healthcare to everyone on Medicare. This includes a health equity-based focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease.

Press Contact:
Andrew Still-Baxter
press@cloverhealth.com

Investor Relations Contact:
Ryan Schmidt
investors@cloverhealth.com